307180.KQ IL Science Co. Ltd
- Market cap
- KRW 177B
- P/E
- -
- P/B
- 4.17x
- ROE
- -6.2%
- Dividend yield
- 0.64%
- Fundamental score
- 1.1/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 307180.KQ undervalued?
Graham numberThe Graham number of IL Science Co. Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
IL Science Co. Ltd fundamental analysis
4 of 21 checks passedROE 0/2
Low return on equity (-6.2%), below 10%.
ROA 0/1
Return on assets (-1.5%) is below the industry median (-0.8%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-2,104.0%) is below the industry median (-42.0%).
Revenue Growth 2/2
Revenue grew 27.9% a year over the past 3 years.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (12.9%), 40% or less.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Cash Runway 0/2
Cash covers 0.1 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (4.2x) is above the industry median (0.5x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
Dividend yield (0.6%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
IL Science Co. Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About IL Science Co. Ltd
IL CO.,LTD. engages in the development, manufacture, wholesale, retail, and installation of lighting products and electrical work. It offers head light, signal light, and headlight; LED module, LED flood light, and LED interior light; FOLLINIC scalp care device and surgical equipment light; and other products. The company also provides Kailux, a AIoT smart lighting platform; INNOSAVER, a wireless automatic power saving system that dramatically reduces electrical energy; and …
Full company profileIL Science Co. Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
IL Science Co. Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 0.00 | 20.3B | 17.6B | 48.6B | 49.2B | 39.1B | 83.5B | 103B | 100B |
| Gross Profit | - | 5.20B | 2.46B | 13.6B | 10.2B | 5.08B | 18.4B | 8.94B | 17.2B |
| Operating Income | -158M | 1.09B | -5.14B | 2.50B | -1.34B | -16.7B | 5.07B | -8.06B | 5.83B |
| EBITDA | - | - | - | - | 6.34B | -11.7B | 13.5B | -545M | 10.1B |
| Net Income | -131M | -2.73B | -4.57B | -8.53B | 1.94B | -18.6B | 432M | -11.1B | -2.65B |
| EPS | -30 | -139 | -215 | -380 | 82 | -695 | 16 | -320 | -72 |
| Balance Sheet | |||||||||
| Total Assets | 9.84B | 27.2B | 40.2B | 72.9B | 72.8B | 79.4B | 138B | 155B | 179B |
| Total Liabilities | 1.23B | 15.0B | 31.3B | 64.9B | 57.1B | 65.0B | 126B | 132B | 133B |
| Shareholders' Equity | 8.61B | 12.2B | 8.89B | 7.99B | 15.7B | 5.70B | 12.0B | 19.8B | 42.6B |
| Cash & Short-term Investments | 9.84B | 6.88B | 5.80B | 8.05B | 3.08B | 10.0B | 8.31B | 1.31B | 3.45B |
| Total Debt | 1.23B | 6.54B | 15.0B | - | - | - | - | - | - |
| Cash Flow | |||||||||
| Operating Cash Flow | -157M | -792M | -4.92B | -7.12B | 1.56B | -5.21B | -3.98B | -1.12B | -31.8B |
| Capital Expenditure | 0.00 | 5.29B | 6.80B | 7.71B | 6.29B | 5.03B | 7.01B | 10.9B | 16.0B |
| Free Cash Flow | - | - | -12.4B | -14.8B | -4.73B | -10.3B | -11.1B | -12.0B | -47.9B |
| Ratios | |||||||||
| ROE | -1.5% | -22.4% | -51.4% | -106.8% | 12.4% | -325.3% | 3.6% | -56.2% | -6.2% |
| ROA | -1.3% | -10.0% | -11.4% | -11.7% | 2.7% | -23.4% | 0.3% | -7.2% | -1.5% |
| Net Profit Margin | - | -13.4% | -26.0% | -17.5% | 3.9% | -47.5% | 0.5% | -10.8% | -2.6% |
| Debt to Equity | 0.14x | 0.54x | 1.69x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
IL Science Co. Ltd dividends
- Dividend yield
- 0.64%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 1.13B | 32 | - |
| 2024 | KRW 375M | 14 | 86.9% |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns IL Science Co. Ltd
- Insiders 26.12%
- Institutions 0.06%
- Public & others 73.82%
- Shares outstanding 36.9M
- Free float 28.7M
IL Science Co. Ltd company profile
- Company name
- IL Science Co. Ltd
- Ticker
- 307180.KQ
- ISIN
- KR7307180000
- Exchange
- KOSDAQ
- Sector
- Technology
- Industry
- Building Products
- Employees
- 139
- Fiscal year end
- December
- Address
- 25, Beobwon-ro 11-gil, Seoul, South Korea
- Phone
- 82 2 2039 8039
- Website
- il.co.kr
About IL Science Co. Ltd
IL CO.,LTD. engages in the development, manufacture, wholesale, retail, and installation of lighting products and electrical work. It offers head light, signal light, and headlight; LED module, LED flood light, and LED interior light; FOLLINIC scalp care device and surgical equipment light; and other products. The company also provides Kailux, a AIoT smart lighting platform; INNOSAVER, a wireless automatic power saving system that dramatically reduces electrical energy; and EV charging streetlight, a charging streetlight system for electric vehicles. The company was formerly known as IL Science Co., Ltd. and changed its name to IL CO.,LTD. in April 2025. IL CO.,LTD. was founded in 2008 and is based in Seoul, South Korea.
IL Science Co. Ltd management
5- Mr. Song Seong-GeunCEO & Representative Director · born 1985
- Mr. Hyo-seong YoonExecutive VP & CFO · born 1970
- Mr. Deok-Jung KimMD & Inside Director · born 1977
- Mr. Sang-heon LeeManaging Director · born 1971
- Mr. Ho-min RyuManaging Director · born 1977